Drugs / VE818
Trials 0
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07207434 Comparator | Aug 2025 → Aug 2026 overdue | — | Aga Khan University | Recruiting | No outcome recorded |
| Phase 2 | NCT07134790 Comparator | Jul 2025 → Jul 2026 overdue | — | University Ghent | Recruiting | No outcome recorded |
| Phase 2 | NCT06817031 Comparator | Apr 2025 → Apr 2026 overdue | — | International Centre for Diarrhoeal Disease Research, Bangladesh | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VE818 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07134790 ↗ |
| Modality | Other / unclassified | “11-strain bacterial consortium” NCT06817031 ↗ |